| (EUR) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 9.32M | — |
| Operating expense | — | — |
| Net income | -61.62M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, 0GT.F returned +65.9% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +1.4% |
| 1 year | +65.9% |
| 5 years | +24.5% |
| All-time high | €51.50 (Jan 2021) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what €1,000 in 0GT.F would be worth today ›No. Stoke Therapeutics, Inc. has not paid a dividend in the past 12 months.
Stoke Therapeutics, Inc. is part of the Healthcare sector.
Stoke Therapeutics, Inc. has a market cap of 1.77B EUR, based on the latest quote.
Stoke Therapeutics, Inc. is expected to report earnings around Nov 3, 2026. That date is an estimate and has not been confirmed by the company.
